Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 47 | 0 | 5 | 0 | €699.70 | €755.83 | 8.022% |
Vertex Pharmaceuticals Inc. | 39 | 2 | 4 | 0 | €368.55 | €382.71 | 3.841% |
Boston Scientific | 37 | 0 | 4 | 0 | €63.50 | €61.53 | -3.109% |
Intuitive Surgical Inc | 35 | 0 | 3 | 0 | €364.80 | €368.20 | 0.932% |
UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €464.55 | €543.72 | 17.042% |
Regeneron Pharmaceuticals Inc. | 31 | 1 | 5 | 1 | €834.20 | €954.29 | 14.396% |
Merck & Co. Inc. | 27 | 1 | 4 | 0 | €117.60 | €124.92 | 6.221% |
Trinity Biotech ADR | 24 | 0 | 3 | 0 | €0.41 | - | - |
Thermo Fisher Scientific Inc. | 24 | 0 | 3 | 0 | €505.30 | €561.51 | 11.123% |
Edwards Lifesciences Corp. | 24 | 1 | 4 | 0 | €80.41 | €87.81 | 9.198% |
Amgen Inc. | 23 | 0 | 3 | 0 | €247.85 | €293.65 | 18.478% |
Cytokinetics Inc. | 24 | 1 | 4 | 0 | €62.00 | €88.82 | 43.263% |
Neurocrine Bioscience | 21 | 0 | 3 | 0 | €125.00 | €137.10 | 9.680% |
Intra-Cellular Therapies Inc. | 21 | 0 | 5 | 0 | €66.50 | €77.61 | 16.711% |
Humana Inc. | 20 | 0 | 3 | 0 | €305.30 | €473.29 | 55.023% |